Tandem Diabetes Care (TNDM) Gross Profit Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Gross Profit Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.95% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 15.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.04% |
| Mar 31, 2026 | 15.52% |
| Dec 31, 2025 | 6.35% |
| Sep 30, 2025 | 7.73% |
| Jun 30, 2025 | 11.58% |
| Mar 31, 2025 | 25.07% |
| Dec 31, 2024 | 68.77% |
| Sep 30, 2024 | 38.88% |
| Jun 30, 2024 | 10.87% |
| Mar 31, 2024 | 14.19% |
| Dec 31, 2023 | -19.24% |
| Sep 30, 2023 | -14.05% |
| Jun 30, 2023 | -0.21% |
| Mar 31, 2023 | -8.99% |
| Dec 31, 2022 | 1.58% |
| Sep 30, 2022 | 7.94% |
| Jun 30, 2022 | 10.27% |
| Mar 31, 2022 | 24.30% |
| Dec 31, 2021 | 25.59% |
| Sep 30, 2021 | 48.13% |